144 results
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
or report filed with the SEC for the purpose of updating the description including without limitation, Exhibit 4.2 of our Annual Report on Form 10-K … for such purpose set such value as the liquidator deems fair upon any one or more class or classes of property and may determine how such division
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the best knowledge of the Company … or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order
S-3
EX-5.1
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
2024 (the “Sales Ordinary Shares” and, together with the New Ordinary Shares, the “Shares”) (the “Sales Agreement”).
INTRODUCTION
Purpose … , a limited liability partnership organised under the laws of Delaware.
15 May 2024
Page 2
Legal review
For the purpose of issuing this letter, we
8-K
EX-99.1
MREO
Mereo Biopharma Group Plc
15 May 24
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
completed. The analysis concluded that the current SGRQ instrument is fit for purpose with valid content measures for patients with AATD-LD
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
before any adjourned meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the time stamp applied to the message … of shareholders;
-21-
the appointment, compensation, retention and oversight of any accounting firm engaged for the purpose of preparing or issuing
10-K
EX-10.30
cs6un3 5oquc
27 Mar 24
Annual report
5:20pm
10-K
EX-19.1
opdw0 0s59lduyyu
27 Mar 24
Annual report
5:20pm
10-K
86fathm 1fpspdi
27 Mar 24
Annual report
5:20pm
10-K
EX-4.2
hcr e9r987av2v0y0
27 Mar 24
Annual report
5:20pm
S-8
w6wak
23 Jan 24
Registration of securities for employees
4:16pm
S-8
EX-4.3
u6d1u
23 Jan 24
Registration of securities for employees
4:16pm
S-8
p3rrb1phekv1ht jvozi
23 Jan 24
Registration of securities for employees
4:16pm
S-8
EX-5.1
awiud 1assb
23 Jan 24
Registration of securities for employees
4:16pm
6-K
EX-3.1
375vv54 l0
18 Dec 23
Current report (foreign)
4:10pm
6-K
EX-99.1
7f1 3l5v9av65cnzvo
16 Nov 23
Current report (foreign)
7:01am
6-K
EX-99.2
1tjiq0q0hv09pevmllot
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.2
81wbsrgm
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
EX-99.1
eys ss1j0
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
EX-3.1
zsf7si17nypm
17 May 22
Current report (foreign)
8:26am